Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Jul 2021)

Time‐Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above‐Normal Blood Pressure

  • Daniel H. Craighead,
  • Thomas C. Heinbockel,
  • Kaitlin A. Freeberg,
  • Matthew J. Rossman,
  • Rachel A. Jackman,
  • Lindsey R. Jankowski,
  • Makinzie N. Hamilton,
  • Brian P. Ziemba,
  • Julie A. Reisz,
  • Angelo D’Alessandro,
  • L. Madden Brewster,
  • Christopher A. DeSouza,
  • Zhiying You,
  • Michel Chonchol,
  • E. Fiona Bailey,
  • Douglas R. Seals

DOI
https://doi.org/10.1161/JAHA.121.020980
Journal volume & issue
Vol. 10, no. 13

Abstract

Read online

Background High‐resistance inspiratory muscle strength training (IMST) is a novel, time‐efficient physical training modality. Methods and Results We performed a double‐blind, randomized, sham‐controlled trial to investigate whether 6 weeks of IMST (30 breaths/day, 6 days/week) improves blood pressure, endothelial function, and arterial stiffness in midlife/older adults (aged 50–79 years) with systolic blood pressure ≥120 mm Hg, while also investigating potential mechanisms and long‐lasting effects. Thirty‐six participants completed high‐resistance IMST (75% maximal inspiratory pressure, n=18) or low‐resistance sham training (15% maximal inspiratory pressure, n=18). IMST was safe, well tolerated, and had excellent adherence (≈95% of training sessions completed). Casual systolic blood pressure decreased from 135±2 mm Hg to 126±3 mm Hg (P0.05). Twenty‐four hour systolic blood pressure was lower after IMST versus sham training (P=0.01). Brachial artery flow‐mediated dilation improved ≈45% with IMST (P0.05). Conclusions High‐resistance IMST is a safe, highly adherable lifestyle intervention for improving blood pressure and endothelial function in midlife/older adults with above‐normal initial systolic blood pressure. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03266510.

Keywords